Geron (GERN) Research & Development (2010 - 2026)
Geron's Research & Development was $22.03 million in Q2 2026, up 1.4% from $21.74 million a year earlier and up 47.3% from the prior quarter.
Powered by 
Analysis
Geron (GERN) Research & Development (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Geron's Research & Development was $71.61 million through Jun 30, 2026, down 10.9% year-over-year; for FY2025, it came in at $71.43 million, down 31.1% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 6.8% (FY2020 to FY2025).
- In earlier years, Research & Development was $103.74 million in FY2024 (-17.0%), $125.05 million in FY2023 (+30.9%), $95.52 million in FY2022 (+11.4%) and $85.73 million in FY2021 (+66.5%).
- The Q2 2026 figure marks the highest quarterly Research & Development since Q4 2024.
- Compared with a year earlier, Research & Development was higher in two of the last eight quarters, with an average decline of 21.9%.
- The best year-over-year quarter for Research & Development over five years was Q2 2023 (growth of 72.2%); the worst was Q1 2025 (a decline of 48.7%).
- Per Business Quant data, GERN's Research & Development in the three quarters before Q2 2026 was $14.96 million (Q1 2026), $13.55 million (Q4 2025) and $21.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Geron | 777.25 Mn | -574.46 Mn | - | 22.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.03 Mn |
| Mar 31, 2026 | 14.96 Mn |
| Dec 31, 2025 | 13.55 Mn |
| Sep 30, 2025 | 21.07 Mn |
| Jun 30, 2025 | 21.74 Mn |
| Mar 31, 2025 | 15.08 Mn |
| Dec 31, 2024 | 23.43 Mn |
| Sep 30, 2024 | 20.15 Mn |
| Jun 30, 2024 | 30.78 Mn |
| Mar 31, 2024 | 29.37 Mn |
| Dec 31, 2023 | 32.91 Mn |
| Sep 30, 2023 | 29.43 Mn |
| Jun 30, 2023 | 35.49 Mn |
| Mar 31, 2023 | 27.22 Mn |
| Dec 31, 2022 | 28.21 Mn |
| Sep 30, 2022 | 24.60 Mn |
| Jun 30, 2022 | 20.61 Mn |
| Mar 31, 2022 | 22.10 Mn |
| Dec 31, 2021 | 24.15 Mn |
| Sep 30, 2021 | 18.53 Mn |
API Access
Geron Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=GERN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "GERN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=GERN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();